Log in to search using one of your social media accounts:

 

Drug Combo Boosts 1-Year CABG Vein Graft Patency (CME/CE)
(MedPage Today) -- Ticagrelor and aspirin together better than aspirin alone (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 24, 2018 Category: Cardiology Source Type: news

Ticagrelor & #43; Aspirin Beneficial After Elective CABG
TUESDAY, April 24, 2018 -- For patients undergoing elective coronary artery bypass grafting (CABG), ticagrelor + aspirin is associated with significantly increased saphenous vein graft patency rates compared with aspirin alone, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 24, 2018 Category: Pharmaceuticals Source Type: news

Use of 2 anti-clotting medications following bypass surgery improves outcomes for grafted veins
(JAMA Network) Taking aspirin plus an anti-clotting medication for one year after heart bypass surgery resulted in less narrowing of the vein used to bypass a blocked artery than taking aspirin alone. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 24, 2018 Category: International Medicine & Public Health Source Type: news

Taking aspirin after losing a loved one could prevent heart attacks
In a University of Arizona study the over-the-counter painkiller was found to decrease the effects of grief-related stress in grieving people who have are 20 times more likely to suffer a heart attack. (Source: the Mail online | Health)
Source: the Mail online | Health - April 19, 2018 Category: Consumer Health News Source Type: news

How simple aspirin may help perk up a chap's love life
In a recent study by researchers in Turkey, eight out of ten men who were given the pill daily for six weeks were able to have satisfactory sex with their partner. (Source: the Mail online | Health)
Source: the Mail online | Health - April 17, 2018 Category: Consumer Health News Source Type: news

Why you should never take aspirin with other painkillers
For more than a decade, Cleveland Clinic scientists have been working on the largest ever investigation into the specific risks associated with each drug. (Source: the Mail online | Health)
Source: the Mail online | Health - April 16, 2018 Category: Consumer Health News Source Type: news

Survival basics: An easy guide to building your own apothecary
(Natural News) Water. Check. Storable food. Check. Medicinal herb garden. Wait, what? If you’re a “prepper” type who’s been stocking up on survival supplies in anticipation of a potential emergency scenario, perhaps you’ve overlooked the importance of developing your own personal “pharmacy” for when things hit the fan. Having bandages and aspirin on hand is... (Source: NaturalNews.com)
Source: NaturalNews.com - April 13, 2018 Category: Consumer Health News Source Type: news

Pycnogenol: a powerful, effective alternative to aspirin as a blood thinner
(Natural News) No one wants to have a heart attack, so many people take aspirin every day in an effort to reduce their risk. Its blood-thinning properties may indeed be helpful when it comes to preventing heart attacks, but aspirin is far from the harmless medicine that it’s made out to be. It might be... (Source: NaturalNews.com)
Source: NaturalNews.com - April 5, 2018 Category: Consumer Health News Source Type: news

Yosprala(TM) in At-Risk Patients Requiring Low-Dose Aspirin Yosprala(TM) in At-Risk Patients Requiring Low-Dose Aspirin
Do the benefits of Yosprala(TM) therapy outweigh its costs when compared with combination therapy with aspirin and a proton-pump inhibitor taken as individual products?Medscape Pharmacists (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 27, 2018 Category: Consumer Health News Tags: Pharmacist Ask the Expert Source Type: news

Aspirin Linked to Lower Mortality in Diabetes With Heart Failure Aspirin Linked to Lower Mortality in Diabetes With Heart Failure
Researchers were surprised to see a paradoxical increase in nonfatal MI and stroke in parallel with lower mortality with aspirin for primary prevention in patients with diabetes and heart failure.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 9, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

FDA Drug Safety Communication: FDA warns about serious bleeding risk with over-the-counter antacid products containing aspirin
[06-06-2016] The U.S. Food and Drug Administration (FDA) is warning consumers about the risk of serious bleeding when using nonprescription, also known as over-the-counter or OTC, aspirin-containing antacid products to treat heartburn, sour stomach, acid indigestion, or upset stomach. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 8, 2018 Category: Drugs & Pharmacology Source Type: news

Is Aspirin the New (Old) Immunotherapy? Is Aspirin the New (Old) Immunotherapy?
Dr David Kerr on how this time-tested drug enhances more complex and expensive immunotherapies.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 1, 2018 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Daily Aspirin Has Heart Benefits, But Risks Too
The study found the daily pill can reduce the risk for heart failure-related hospitalization and death in people who have both conditions.  However, it also found that a daily aspirin raises their risk for nonfatal heart attack and stroke. (Source: WebMD Health)
Source: WebMD Health - March 1, 2018 Category: Consumer Health News Source Type: news

Daily Aspirin Can Bring Heart Benefits, But Risks Too
THURSDAY, March 1, 2018 -- For people who have both type 2 diabetes and heart failure, new research offers a mixed message on taking a daily low-dose aspirin. The study found the daily pill can reduce the risk for heart failure-related... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 1, 2018 Category: General Medicine Source Type: news

Daily Aspirin Can Bring Heart Benefits, But Risks Too
Title: Daily Aspirin Can Bring Heart Benefits, But Risks TooCategory: Health NewsCreated: 3/1/2018 12:00:00 AMLast Editorial Review: 3/1/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - March 1, 2018 Category: Cardiology Source Type: news

Daily dose of aspirin ‘beats diabetes and heart disease’
DAILY aspirin can help people with potentially deadly Type 2 diabetes and heart failure to live longer, research suggests. (Source: Daily Express - Health)
Source: Daily Express - Health - March 1, 2018 Category: Consumer Health News Source Type: news

Aspirin lowers risk of death for patients with diabetes, heart failure
(American College of Cardiology) For people living with both Type 2 diabetes and heart failure, taking an aspirin each day appears to lower the risk of dying or being hospitalized for heart failure, according to research being presented at the American College of Cardiology's 67th Annual Scientific Session. But the data also reveal aspirin use may increase the risk of nonfatal heart attack or stroke, a somewhat contradictory finding that surprised researchers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 28, 2018 Category: International Medicine & Public Health Source Type: news

Feb 23, 2018 This Week in Cardiology Feb 23, 2018 This Week in Cardiology
Atrial fibrillation after cardiac surgery, radial vs ulnar cath access, aspirin for heart failure, VTE prophylaxis and low-fat vs high-carb diets are discussed in this week's podcast.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 23, 2018 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

The Nasal Flu Vaccine Is Set to Come Back Next Year. Here ’s What to Know About It
After a two-year hiatus, the nasal flu vaccine is set to return to doctors’ offices next year. The Advisory Committee on Immunization Practices (ACIP) voted 12 to 2 on Wednesday to return the nasal spray to the CDC’s list of recommended vaccines for the 2018-2019 flu season. Pending final approval from the CDC director, the vote would greenlight the spray for widespread use and compel insurance companies to cover it. The committee stopped short of explicitly recommending the nasal spray, however, and will instead let providers and patients decide if they’ll use it instead of traditional flu shots. There ...
Source: TIME: Health - February 22, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime medicine onetime Source Type: news

Aspirin as Good a Clot Buster as Pricey Drugs After Joint Replacement
Title: Aspirin as Good a Clot Buster as Pricey Drugs After Joint ReplacementCategory: Health NewsCreated: 2/21/2018 12:00:00 AMLast Editorial Review: 2/22/2018 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - February 22, 2018 Category: Rheumatology Source Type: news

Aspirin A Good Clot Buster After Knee Replacement
Few patients in the study developed a blood clot after surgery, and those on aspirin fared just as well as those on rivaroxaban. (Source: WebMD Health)
Source: WebMD Health - February 21, 2018 Category: Consumer Health News Source Type: news

Aspirin just as good as Xarelto for preventing clots after hip, knee surgery
(Reuters Health) - The expensive anti-clotting drug Xarelto is no better than common aspirin when it comes to preventing painful and potentially-deadly clots in people who have just had total hip or total knee replacement surgery, according to a new Canadian study. (Source: Reuters: Health)
Source: Reuters: Health - February 21, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

DVT Prevention: Aspirin, Rivaroxaban Similar After Arthroplasty DVT Prevention: Aspirin, Rivaroxaban Similar After Arthroplasty
Among patients who underwent total hip or knee replacement, aspirin was noninferior to rivaroxaban for preventing VTE or PE after an initial 5-day course of rivaroxaban, a large trial found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 21, 2018 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

Joint Surgery: Aspirin Equals NOAC for Post-Acute VTE Prevention
(MedPage Today) -- Switch to ASA after initial NOAC safe, just as protective in EPCAT II trial (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - February 21, 2018 Category: Surgery Source Type: news

Aspirin as Good a Clot Buster as Pricey Drugs After Joint Replacement
WEDNESDAY, Feb. 21, 2018 -- Good old aspirin is just as effective as newer, expensive drugs at preventing blood clots after hip or knee replacement, a new clinical trial suggests. Researchers said the findings could change some doctors'prescribing... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 21, 2018 Category: General Medicine Source Type: news

Low-Dose Aspirin in Heart Failure Sans AF: Recommended or Not? Low-Dose Aspirin in Heart Failure Sans AF: Recommended or Not?
It's an old question still, without much solid evidence either way. How much does a new cohort study from Denmark add to the debate? Views differ on whether aspirin should have a role in this population.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 16, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

ESO Launches 2018 ESO EMS Index to Track Nationwide EMS Performance Across Five Metrics
AUSTIN, Texas – ESO Solutions, Inc., the leading data and software company serving emergency medical services (EMS), hospitals and fire departments, today announced the findings of its inaugural report, the 2018 ESO EMS Index. The Index tracks performance of EMS agencies nationwide across five metrics: Stroke assessment and documentation, overdose events, end-tidal carbon dioxide (ETCO2) monitoring, 12-lead electrocardiogram (EKG) use and aspirin administration for chest pain. Data used for the Index are from January 1, 2017 through December 31, 2017. “There are changes on the horizon for EMS agencies across th...
Source: JEMS: Journal of Emergency Medical Services News - February 15, 2018 Category: Emergency Medicine Authors: ESO Solutions Tags: Industry News Source Type: news

Aspirin vs. Plavix
Title: Aspirin vs. PlavixCategory: MedicationsCreated: 2/14/2018 12:00:00 AMLast Editorial Review: 2/14/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - February 14, 2018 Category: Cardiology Source Type: news

Aspirin vs. Plavix (clopidogrel)
Title: Aspirin vs. Plavix (clopidogrel)Category: MedicationsCreated: 2/14/2018 12:00:00 AMLast Editorial Review: 2/14/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - February 14, 2018 Category: Cardiology Source Type: news

Brilinta significantly reduces CV events and coronary death beyond one year in heart attack survivors with multi-vessel disease
AstraZeneca today announced results from a new sub-analysis of the Phase III PEGASUS-TIMI 54 trial, demonstrating a risk reduction of 19% in MACE (the composite of CV death, myocardial infarction, or stroke) (HR 0.81; 95% CI, 0.7-0.95) and of 36% in coronary death (HR 0.64; 95% CI, 0.45-0.89) from treatment with Brilinta 60mg (ticagrelor), in combination with low dose aspirin, in people who had survived a heart attack and had stenosis (abnormal narrowing) in two or more coronary blood vessels, a condition known as multi-vessel disease (MVD). (Source: World Pharma News)
Source: World Pharma News - February 7, 2018 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news

Study claims aspirin could cure erectile dysfunction
Turkish researchers claim 120 men achieved a 75 percent erection success rate after six weeks of one daily aspirin. Viagra, meanwhile, markets a success rate between 48 and 81 percent. (Source: the Mail online | Health)
Source: the Mail online | Health - February 7, 2018 Category: Consumer Health News Source Type: news

Cancer breakthrough? An aspirin a day could hold key to stopping the disease
ASPIRIN could play a major role in preventing many types of cancer, scientists say. A study launched today will assess whether the common over-the-counter drug should be taken to reduce risk. (Source: Daily Express - Health)
Source: Daily Express - Health - February 6, 2018 Category: Consumer Health News Source Type: news

Rivaroxaban Plus Aspirin Cuts Stroke Rate in Half Rivaroxaban Plus Aspirin Cuts Stroke Rate in Half
New results from the COMPASS trial show combination therapy reduced the ischemic stroke rate by 49% vs aspirin alone in patients with stable vascular disease, without increasing intracerebral bleeding.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 31, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Aspirin Therapy of No Benefit in Heart Failure Patients Without AF (CME/CE)
(MedPage Today) -- Findings cast doubt on positive results from earlier trial (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - January 30, 2018 Category: Primary Care Source Type: news

Brave toddler meets 24 strangers who saved her life
It took a team of UCLA medical professionals and the generosity of 71 strangers to save 2-year-old Skye Savren-McCormick ’s life.The toddler from Ventura, California, required frequent blood and platelet transfusions, often on a daily basis, while undergoing  three grueling bone-marrow transplants, surgery to remove her swollen spleen and seven rounds of chemotherapy for leukemia and lymphoma. She received 77 units of blood and platelets during a 10-month stay at UCLA Mattel Children ’s Hospital.  Recently Skye ’s family got to meet and thank two dozen of the 71 strangers whose blood a...
Source: UCLA Newsroom: Health Sciences - January 19, 2018 Category: Universities & Medical Training Source Type: news

Could Aspirin Sub for Heparin to Prevent Cancer-Associated Thrombosis?
(MedPage Today) -- Pilot study suggests safety and feasibility, supporting a larger trial (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - January 8, 2018 Category: Cardiology Source Type: news

What COMPASS and RE-DUAL Mean for Aspirin and Triple Therapy What COMPASS and RE-DUAL Mean for Aspirin and Triple Therapy
Drs Cohen and O'Donoghue review new data from the COMPASS and RE-DUAL PCI trials and potential strategies for patients who need anticoagulation and antiplatelet therapy.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 4, 2018 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

High-Dose Aspirin Preferred for Kawasaki's (CME/CE)
(MedPage Today) -- Low doses raise risk of IVIG resistance (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - January 3, 2018 Category: Pediatrics Source Type: news

Equagesic (Meprobamate and Aspirin) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 29, 2017 Category: Drugs & Pharmacology Source Type: news

Regular Aspirin Use May Slow COPD Progression (CME/CE)
(MedPage Today) -- Analysis showed 50% reduction in emphysema progression (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - December 23, 2017 Category: Allergy & Immunology Source Type: news

Gingko biloba may help boost memory and function after stroke
The herbal extract Gingko biloba may help stroke patients recover better than just taking aspirin, according to Chinese researchers. (Source: Nursing Times)
Source: Nursing Times - December 22, 2017 Category: Nursing Source Type: news

Your NEJM Group Today: Date Night with the EHR / Low-Dose Aspirin & Intracranial Bleeding / California FM Opportunity
Take a look at today's offering from NEJM Group: NEJM Catalyst: Infographic: Date Night with the Electronic Health Record: Two experts urge individuals and organizations... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 22, 2017 Category: Primary Care Source Type: news

Gingko biloba May Protect Cognition in Stroke Patients Gingko biloba May Protect Cognition in Stroke Patients
In a small randomized trial, the herbal extract as an adjunct to aspirin showed less cognitive decline vs aspirin alone in patients with ischemic stroke and was safe.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 20, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Medical News Today: Stroke: This herbal extract could improve brain function
Those who have experienced ischemic stroke may benefit from taking a combination of ginkgo biloba extract and aspirin, a new study suggests. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 19, 2017 Category: Consumer Health News Tags: Stroke Source Type: news

Herbal supplement boosts memory in stroke survivors
Researchers from Nanjing University in China found ginkgo bilboa improves stroke sufferers' attention, reflexes and language skills in as little as 12 weeks when taken with aspirin, which thins the blood. (Source: the Mail online | Health)
Source: the Mail online | Health - December 19, 2017 Category: Consumer Health News Source Type: news

Ginkgo Biloba Use After Stroke Tied to Less Cognitive Decline
Ginkgo biloba extract plus aspirin is associated with less cognitive decline following stroke, compared with aspirin alone, according to a study in Stroke and Vascular... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 19, 2017 Category: Primary Care Source Type: news

Supplement boosts memory in stroke survivors
Researchers from Nanjing University in China found ginkgo bilboa improves stroke sufferers' attention, reflexes and language skills in as little as 12 weeks when taken with aspirin, which thins the blood. (Source: the Mail online | Health)
Source: the Mail online | Health - December 18, 2017 Category: Consumer Health News Source Type: news

Aspirin, NSAIDs and Prospective Risk of HER2+ Breast Cancer Aspirin, NSAIDs and Prospective Risk of HER2+ Breast Cancer
Does aspirin or ibuprofen reduce risk of HER2+ breast cancer?Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 15, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

11.12.17: Not intended for U.S. and UK Media
Bayer's rivaroxaban submitted to U.S. FDA for approval in patients with coronary and/or peripheral artery diseaseThe rivaroxaban vascular dose, 2.5 mg twice daily plus aspirin 100 mg once daily, demonstrated a 24% reduction in the combined risk of stroke, cardiovascular death and heart attack / The application for marketing approval is based on the COMPASS studymehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - December 10, 2017 Category: Pharmaceuticals Source Type: news

Diabetes drug and aspirin boosts cancer drug effectiveness
Metformin may slow breast cancer growth, a study by the University of Saskatchewan in Canada found. Adding aspirin to a cancer drug could help combat pancreatic, lung and colorectal cancers. (Source: the Mail online | Health)
Source: the Mail online | Health - December 6, 2017 Category: Consumer Health News Source Type: news